267 related articles for article (PubMed ID: 29345014)
1. Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa.
Artero Castro A; Lukovic D; Jendelova P; Erceg S
Stem Cells; 2018 Apr; 36(4):474-481. PubMed ID: 29345014
[TBL] [Abstract][Full Text] [Related]
2. Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells.
Artero-Castro A; Long K; Bassett A; Ávila-Fernandez A; Cortón M; Vidal-Puig A; Jendelova P; Rodriguez-Jimenez FJ; Clemente E; Ayuso C; Erceg S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672445
[TBL] [Abstract][Full Text] [Related]
3. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
Maeda A; Mandai M; Takahashi M
Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
Dalvi S; Galloway CA; Singh R
Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
[TBL] [Abstract][Full Text] [Related]
5. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach.
Gagliardi G; Ben M'Barek K; Goureau O
Prog Retin Eye Res; 2019 Jul; 71():1-25. PubMed ID: 30885665
[TBL] [Abstract][Full Text] [Related]
6. Human iPSC derived disease model of MERTK-associated retinitis pigmentosa.
Lukovic D; Artero Castro A; Delgado AB; Bernal Mde L; Luna Pelaez N; Díez Lloret A; Perez Espejo R; Kamenarova K; Fernández Sánchez L; Cuenca N; Cortón M; Avila Fernandez A; Sorkio A; Skottman H; Ayuso C; Erceg S; Bhattacharya SS
Sci Rep; 2015 Aug; 5():12910. PubMed ID: 26263531
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease.
Giacalone JC; Wiley LA; Burnight ER; Songstad AE; Mullins RF; Stone EM; Tucker BA
Stem Cells Transl Med; 2016 Feb; 5(2):132-40. PubMed ID: 26683869
[TBL] [Abstract][Full Text] [Related]
8. Personalized therapeutic strategies for patients with retinitis pigmentosa.
Zheng A; Li Y; Tsang SH
Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
[TBL] [Abstract][Full Text] [Related]
9. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
10. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Leong YC; Sowden JC
Adv Exp Med Biol; 2023; 1415():555-563. PubMed ID: 37440086
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
[TBL] [Abstract][Full Text] [Related]
12. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
[TBL] [Abstract][Full Text] [Related]
13. Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice.
Barnea-Cramer AO; Wang W; Lu SJ; Singh MS; Luo C; Huo H; McClements ME; Barnard AR; MacLaren RE; Lanza R
Sci Rep; 2016 Jul; 6():29784. PubMed ID: 27405580
[TBL] [Abstract][Full Text] [Related]
14. Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.
Liu W; Liu S; Li P; Yao K
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563274
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa.
Tucker BA; Scheetz TE; Mullins RF; DeLuca AP; Hoffmann JM; Johnston RM; Jacobson SG; Sheffield VC; Stone EM
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E569-76. PubMed ID: 21825139
[TBL] [Abstract][Full Text] [Related]
16. Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis Pigmentosa.
de Bruijn SE; Fiorentino A; Ottaviani D; Fanucchi S; Melo US; Corral-Serrano JC; Mulders T; Georgiou M; Rivolta C; Pontikos N; Arno G; Roberts L; Greenberg J; Albert S; Gilissen C; Aben M; Rebello G; Mead S; Raymond FL; Corominas J; Smith CEL; Kremer H; Downes S; Black GC; Webster AR; Inglehearn CF; van den Born LI; Koenekoop RK; Michaelides M; Ramesar RS; Hoyng CB; Mundlos S; Mhlanga MM; Cremers FPM; Cheetham ME; Roosing S; Hardcastle AJ
Am J Hum Genet; 2020 Nov; 107(5):802-814. PubMed ID: 33022222
[TBL] [Abstract][Full Text] [Related]
17. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
Ma C; Jin K; Jin ZB
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
[TBL] [Abstract][Full Text] [Related]
18. Modeling retinitis pigmentosa through patient-derived retinal organoids.
Li YP; Deng WL; Jin ZB
STAR Protoc; 2021 Jun; 2(2):100438. PubMed ID: 33899019
[TBL] [Abstract][Full Text] [Related]
19. Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease.
Móvio MI; de Lima-Vasconcellos TH; Dos Santos GB; Echeverry MB; Colombo E; Mattos LS; Resende RR; Kihara AH
Semin Cell Dev Biol; 2023 Jul; 144():77-86. PubMed ID: 36210260
[TBL] [Abstract][Full Text] [Related]
20. hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges.
Lukovic D; Moreno-Manzano V; Rodriguez-Jimenez FJ; Vilches A; Sykova E; Jendelova P; Stojkovic M; Erceg S
Neuroscientist; 2017 Oct; 23(5):554-566. PubMed ID: 28281409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]